)
Jimmy El Hokayem
Vice President, Program Development and Medical Insights,
Biorasi
As part of Biorasi leadership, Dr. El-Hokayem holds a unique expertise in C&G therapy development spanning from basic science to successful clinical trial execution. He currently sits on the scientific advisory board of the FAST foundation. Dr El-Hokayem has numerous published contributions on early models of iPSC derivation from PBMCs.
Sessions
-
24-Jun-2024Salon DSponsor Led Roundtable: Utilizing Innovative Strategies and Collaborations to Address Challenges in Neurodegenerative Trials [Clinical Studies Topic]
-
18-Jun-2024Salon HSpotlight Presentation: Navigating Precision Oncology Clinical Trials: Paradigm Shifts Critical for Current Trial Needs